# A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants

> **NCT02525484** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 44 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Pirfenidone

## Key facts

- **NCT ID:** NCT02525484
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02525484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02525484, "A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02525484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*